4Hitomi Mori,Kazuhiko Takahashi,Takaharu Mizutani.Interaction Between Valproic Acid and Carbapenem Antibiotics[J].Drug Metabolism Reviews.2007(4)
二级参考文献19
1Munar MY,Singh H.Drug dosing adjustments in patients with chronic kidney disease[J].Am Fam Physician,2007,75(10):1487-1496.
2Gabardi S,Abramson S.Drug dosing in chronic kidney disease[J].Med Clin North Am,2005,89(3):649-687.
3Bagley WH, Yang H, Shah KH. Rhabdomyolysis [J]. Intern E- merg Med, 2007, 2(3): 210-218.
4Burtenslaaw AJ, Sellors G, Downing R. Presumed interaction of fusidic acid with simvastatin [J]. Anaesthesia, 2008, 63 (6): 656-658.
5Kotanko P, KJrisits W, Skrabel F. Rhabdomyolysis and acute re- nal graft impairment in a patient treated with simvastatin, tacrolimus and fusidic Acid[J]. Nephron, 2002, 90(2): 234-235.
6Mag~~ CN, Mcdani SA, Lcavey SF, Et al. Severe rhabdomyoly- sis as a conscquanc~ of the interaction of fusidic acid and atorvas- tatin[J]. American Journal of Kidney Disease, 2010, 56(5): el 1-15.
7O'Mahony C, Campbell VL, Al-Khayatt MS, et al. Rhabdomy- olysis with atorvastatin and fusidic acid [J]. Postgraduate Medical Journal, 2008, 84(992): 325-327.
8Wenisch C, Krause R, Fladerer P, et al. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy [J]. Am J Med, 2000, 109(1): 78.
9Yuen SLS, McGarity B. Rhabdomyolysis secondary to interaction of fusidic acid and simvastatin[J]. Med J Aust, 2003, 179(3): 172.
10Remuzzi A, Perico N, Amuchastegui CS, et al. Short-and long-term effect ofangiotensin Ⅱ receptor blockade in rats with experimental diabetes. J Am Soc Nephrol,1993, 4: 40～49
